Wang W, Liu B, Sun S, et al. *Onco Targets Ther*. 2020;13:1649--1659.

The authors have advised due to an error at the time of figure assembly, duplicate images were used in [Figure 1E](#F0001a){ref-type="fig"} on page 1652.

The correct [Figure 1](#F0001b){ref-type="fig"} is shown below. This error does not affect the results of the paper. The authors apologize for this error. Figure 1Continued. Figure 1Downregulation ofmiR-486-5p enhanced the cytotoxic effect of 5-Fu in pancreatic cancer cells. (**A**) PANC-1 and (**B**) MiaPaCa-2 cells were transfected with 10 nMmiR-486-5p agonist or 10 nMmiR-486-5p antagonist for 48 hrs. RT-qPCR was used to detect the level ofmiR-486-5p in PANC-1 and MiaPaCa-2 cells. (**C**) PANC-1 and (**D**) MiaPaCa-2 cells were transfected with 10 nM miR-486-5p antagonist, and then exposed to 5-Fu for 48 hrs. Cell Counting Kit 8 assay was used to determine the cell viability. (**E, F**) PANC-1 cells were Transfected with 10 nMmiR-486-5p antagonist and then exposed to 5-Fu for 48 hrs. Meanwhile, PANC-1 cells were transfected with 10 nMmiR-486-5p antagonist or exposed to 5-Fu for 48 hrs, respectively. Relative fluorescence expressions were quantified by Ki67 and DAPI staining. \*P\<0.05, \*\*P\<0.01 vs NC group; ^\#\#^P\<0.01 vs 5-FU group.
